Dr. Chris Martin, an accomplished biotech entrepreneur, joined Senya’s Board as a Non-Executive Director.

Dr. Martin co-founded Spirogen and served as its CEO until its acquisition by AstraZeneca. He later co-founded and led ADC Therapeutics, a publicly traded biotech company based in Switzerland. Currently, he serves as Chair of Myricx Therapeutics and Tagworks Pharmaceuticals.